Rotavirus vaccines have revolutionized the prevention of severe diarrhea in children. Two main vaccines, Rotarix and RotaTeq, provide effective protection against rotavirus gastroenteritis. These vaccines target common rotavirus strains, including G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8]. Despite the success of current vaccines, ongoing research focuses on addressing challenges such as strain diversity and the emergence of new strains that may impact vaccine efficacy. Genomic surveillance and characterization of rotavirus strains worldwide contribute to understanding the diversity of circulating viruses. This knowledge informs vaccine development strategies and updates. Advances in understanding the molecular biology of rotavirus, viral-host interactions, and the immune response aid in the development of next-generation vaccines and antiviral treatments. Research also explores the broader impact of rotavirus on gut health, immune modulation, and potential long-term consequences of infection. This comprehensive understanding of rotavirus biology and epidemiology enhances our ability to develop effective prevention and treatment strategies, ultimately reducing the global burden of rotavirus-associated morbidity and mortality.